Form 4 for BIOA BioAge Labs, Inc.
Accepted 2026-01-15 00:00:00 ET · period of report 2026-01-13 · accession 0001120478-26-000003 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-01-15 | 2026-01-13 | BIOA | GOLDSTEIN DOV A MD | CFO | S - Sale+OE | $19.70 | -27.0K | 40.4K | -40% | -$531.8K |
| D | 2026-01-15 | 2026-01-13 | BIOA | GOLDSTEIN DOV A MD | CFO | M - OptEx | $8.39 | +27.0K | 49.4K | +120% | +$226.5K |
| D | 2026-01-15 | 2026-01-13 | BIOA | GOLDSTEIN DOV A MD | CFO | M - OptEx | $0.00 | -27.0K | 92.6K | -23% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-13 | S | D | 4,440 | $19.45 | 35,994 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.00 to $19.86 per share, inclusive. |
| 2 | Common | Common Stock | 2026-01-13 | S | D | 11,663 | $20.54 | 24,331 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.04 to $21.02 per share, inclusive. |
| 3 | Common | Common Stock | 2026-01-13 | S | D | 1,923 | $21.08 | 22,408 | D | — | — | (F5) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.04 to $21.15 per share, inclusive. |
| 4 | Common | Common Stock | 2026-01-13 | S | D | 8,974 | $18.43 | 40,434 | D | — | — | (F2) The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.91 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes 3 through 5 of this Form 4. |
| 5 | Common | Common Stock | 2026-01-13 | M | A | 27,000 | $8.39 | 49,408 | D | — | — | |
| 6 | Derivative | Stock Option (Right to Buy) | 2026-01-13 | M | D | 27,000 | $0.00 | 92,587 | D | $8.39 · — to 2034-04-16 | 27,000 Common Stock | (F6) The option vested or vests as to 1/48th of the total award monthly, with the first tranche vesting on May 17, 2024, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date. Additionally, the entire award is exercisable at any time pursuant to an early exercise feature of the option award. |